5,0
11. Apr. 2018
Aktueller Mitarbeiter, weniger als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great people, extensive knowledge and skills in the more challenging pharma areas, like sterile injectable. Ability to work on many different drugs/products. New CEO is bringing needed operational and process excellence, which will position AMRI for big growth potential in the future.
Kontras
A lot of acquisitions that are not yet integrated. As mentioned in pro's- leadership recognizes the need for integration and process and operational work, which is getting underway, but will take some time.